FTSE 350 Pharmaceuticals & Biotechnology Index (NMX4570) Companies by Market Cap
The FTSE 350 Pharmaceuticals & Biotechnology Index (NMX4570) tracks 6 constituent companies with a combined market cap of $3.41 Billion, covering the largest publicly traded companies in UK. This ranking lists all NMX4570 index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$3.41 Billion
Constituent Companies
6
Index Country
UK
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 1 |
AstraZeneca PLC
LSE:AZN |
% | $2.38 Billion | Healthcare | Drug Manufacturers - General | GBX12610.00 | -1.75% |
| 2 |
GlaxoSmithKline PLC
LSE:GSK |
% | $954.71 Million | Healthcare | Drug Manufacturers - General | GBX1953.50 | -0.41% |
| 3 |
Hikma Pharmaceuticals PLC
LSE:HIK |
% | $42.41 Million | Healthcare | Drug Manufacturers - Specialty & Generic | GBX1574.00 | -0.63% |
| 4 |
Indivior PLC
LSE:INDV |
% | $18.79 Million | Healthcare | Drug Manufacturers - Specialty & Generic | GBX1238.00 | +1.56% |
| 5 |
Genus PLC
LSE:GNS |
% | $16.44 Million | Healthcare | Biotechnology | GBX2034.00 | +0.69% |
| 6 |
Dechra Pharmaceuticals PLC
LSE:DPH
|
% | - | Healthcare | Drug Manufacturers - General | - | - |
Complete list of all companies in the NMX4570 index ranked by market capitalization. Track index constituent performance and market values. View all indices